Arizona Sonoran Copper Stock (OTC: ASCUF)

Latest News for Arizona Sonoran Copper Stock (OTC:ASCUF)

Arizona Sonoran Copper Co Inc is a mineral exploration company. It owns interests in the Cactus Project, located to the southeast of the Phoenix metropolitan area, on private land in Pinal County, Arizona.

ARIZONA SONORAN COPPER CO by Arizona Sonoran Copper Company Inc.

Arizona Sonoran Copper Co Inc

HC Wainwright &amp; Co. analyst Patrick Trucchio reiterates Cybin (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CYBN#AMEX">CYBN</a>) with a Buy and maintains $5 price target.

News

Price Target

Reiteration

Analyst Ratings

CYBN

HC Wainwright & Co. Reiterates Buy on Cybin, Maintains $5 Price Target

Piper Sandler analyst Arvind Ramnani maintains Dayforce (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAY#NYSE">DAY</a>) with a Neutral and maintains $68 price target.

Piper Sandler Maintains Neutral on Dayforce, Maintains $68 Price Target

Needham analyst Anna Andreeva reiterates Wayfair (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/W#NYSE">W</a>) with a Buy and maintains $75 price target.

Needham Reiterates Buy on Wayfair, Maintains $75 Price Target

Deep-pocketed investors have adopted a bullish approach towards Tenet Healthcare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THC#NYSE">THC</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in THC usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 8 extraordinary options activities for Tenet Healthcare. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 62% leaning bullish and 37% bearish. Among these notable options, 2 are puts, totaling $74,410, and 6 are calls, amounting to $578,775.
<h3>What's The Price Target?</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $100.0 and $135.0 for Tenet Healthcare, spanning the last three months.
<h3>Insights into Volume &amp; Open Interest</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Tenet Healthcare's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Tenet Healthcare's significant trades, within a strike price range of $100.0 to $135.0, over the past month.
<h3>Tenet Healthcare Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1715879236_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th style="text-align: right;">Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>THC</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$15.9</td>
<td>$15.6</td>
<td>$15.9</td>
<td>$135.00</td>
<td>$159.0K</td>
<td style="text-align: right;">185</td>
<td style="text-align: right;">200</td>
</tr>
<tr>
<td>THC</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$16.2</td>
<td>$15.6</td>
<td>$15.61</td>
<td>$135.00</td>
<td>$156.0K</td>
<td style="text-align: right;">185</td>
<td style="text-align: right;">300</td>
</tr>
<tr>
<td>THC</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$16.9</td>
<td>$15.3</td>
<td>$15.6</td>
<td>$135.00</td>
<td>$109.2K</td>
<td style="text-align: right;">185</td>
<td style="text-align: right;">77</td>
</tr>
<tr>
<td>THC</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$15.8</td>
<td>$14.6</td>
<td>$15.3</td>
<td>$135.00</td>
<td>$76.5K</td>
<td style="text-align: right;">185</td>
<td style="text-align: right;">402</td>
</tr>
<tr>
<td>THC</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/21/24</td>
<td>$3.0</td>
<td>$2.95</td>
<td>$2.95</td>
<td>$125.00</td>
<td>$45.7K</td>
<td style="text-align: right;">231</td>
<td style="text-align: right;">432</td>
</tr>
</tbody>
</table>

<h3>About Tenet Healthcare</h3>
Tenet Healthcare is a Dallas-based healthcare services organization. It operates a collection of hospitals (about 60 as of December 2023) and over 450 ambulatory surgery centers and other outpatient facilities across the U.S., primarily in the South. Through its Conifer segment, Tenet also provides revenue cycle management solutions.
Following our analysis of the options activities associated with Tenet Healthcare, we pivot to a closer look at the company's own performance.
<h3>Current Position of Tenet Healthcare</h3>
<ul>
<li>Trading volume stands at 258,991, with THC's price down by -2.92%, positioned at $129.09.</li>
<li>RSI indicators show the stock to be may be overbought.</li>
<li>Earnings announcement expected in 74 days.</li>
</ul>
<h3>What Analysts Are Saying About Tenet Healthcare</h3>
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $135.8.
<ul>
<li>An analyst from Barclays has decided to maintain their Overweight rating on Tenet Healthcare, which currently sits at a price target of $147. </li>
<li>Consistent in their evaluation, an analyst from UBS keeps a Buy rating on Tenet Healthcare with a target price of $150. </li>
<li>In a cautious move, an analyst from Mizuho downgraded its rating to Buy, setting a price target of $130. </li>
<li>An analyst from Stephens &amp; Co. persists with their Equal-Weight rating on Tenet Healthcare, maintaining a target price of $122. </li>
<li>An analyst from Truist Securities downgraded its action to Buy with a price target of $130. </li>
</ul>
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Tenet Healthcare with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Options

Markets

Looking At Tenet Healthcare's Recent Unusual Options Activity

Shares of Fluent Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLNT#NASDAQ">FLNT</a>) fell sharply during Thursday's session after posting weaker-than-expected <a href="https://www.benzinga.com/quote/FLNT/earnings">quarterly results.</a>
Fluent posted adjusted loss of 30 cents per share, versus market expectations for a loss of 10 cents per share. The company's quarterly sales came in at $65.983 million missing estimates of $66.433 million, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro.</a>
Fluent shares dipped 12.6% to $3.47 on Thursday.
Here are some other stocks moving in today&#8217;s mid-day session.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Lucy Scientific Discovery Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSDI#NASDAQ">LSDI</a>) shares jumped 239% to $1.75.</li>
<li>Greenwave Technology Solutions, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GWAV#NASDAQ">GWAV</a>) jumped 100% to $0.1196 after jumping around 34% on Wednesday.</li>
<li>Crown ElectroKinetics Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRKN#NASDAQ">CRKN</a>) gained 77.3% to $0.0819 after declining around 3% on Wednesday.</li>
<li>BM Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BMTX#NASDAQ">BMTX</a>) rose 68% to $2.8850 after the company reported better-than-expected first-quarter financial results.</li>
<li>TSR, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSRI#NASDAQ">TSRI</a>) shares climbed 65% to $13.13 after the company announced that it entered into a definitive agreement to be acquired by Vienna Parent.</li>
<li>Pineapple Energy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEGY#NASDAQ">PEGY</a>) rose 55% to $0.1355 after gaining around 48% on Wednesday. Pineapple Energy, last week, reported worse-than-expected first-quarter financial results.</li>
<li>Cyngn Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYN#NASDAQ">CYN</a>) gained 48% to $0.1275 as the company shared several commercial and technological accomplishments from the first quarter of 2024.</li>
<li>Faraday Future Intelligent Electric Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFIE#NASDAQ">FFIE</a>) gained 33.3% to $0.94.</li>
<li>AST SpaceMobile, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASTS#NASDAQ">ASTS</a>) shares rose 32.6% to $3.1711 as the company reported a narrower-than-expected loss for its first quarter and announced a definitive commercial agreement with AT&amp;T Inc.</li>
<li>Bruush Oral Care Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRSH#NASDAQ">BRSH</a>) gained 30.7% to $0.0949.</li>
<li>Sintx Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SINT#NASDAQ">SINT</a>) shares rose 27% to $0.1622 after surging 132% on Wednesday.</li>
<li>Canada Goose Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GOOS#NYSE">GOOS</a>) jumped 23% to $14.10 following better-than-expected fourth-quarter earnings.</li>
<li>Magnite, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGNI#NASDAQ">MGNI</a>) rose 21.6% to $11.91. Needham analyst Laura Martin reiterated Magnite with a Buy and maintained a $15 price target.</li>
<li>Blue Star Foods Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BSFC#NASDAQ">BSFC</a>) gained 17.6% to $0.0760 after adding more than 15% on Wednesday.</li>
<li>Lightspeed Commerce Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LSPD#NYSE">LSPD</a>) climbed 15.3% to $14.74 following upbeat quarterly sales.</li>
<li>Trupanion, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRUP#NASDAQ">TRUP</a>) rose 14.7% to $32.53 after B of A Securities upgraded the stock from Neutral to Buy and raised its price target from $35 to $49.</li>
<li>SilverBow Resources, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SBOW#NYSE">SBOW</a>) gained 14.7% to $37.17 after the company announced that it entered into a definitive agreement to be acquired by Crescent Energy.</li>
<li>VinFast Auto Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VFS#NASDAQ">VFS</a>) rose 12.8% to $4.79. VinFast received 27,649 pre-orders for the VF 3 in Vietnam after 66 hours of accepting deposits.</li>
<li>Corebridge Financial, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRBG#NYSE">CRBG</a>) gained 12.7% to $34.00 after AIG reached a deal to sell shares of its stock in the company to Nippon Life Insurance.</li>
<li>Extreme Networks, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXTR#NASDAQ">EXTR</a>) rose 10.8% to $12.02.</li>
<li>Walmart Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>) gained 6.9% to $63.99 following better-than-expected quarterly earnings.</li>
<li>ZTO Express (Cayman) Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZTO#NYSE">ZTO</a>) shares climbed 6% to $22.67 following upbeat quarterly results</li>
<li>Chubb Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CB#NYSE">CB</a>) gained 4.1% to $263.28 following an SEC filing showed Berkshire Hathaway purchased shares of the stock. The 13F filing revealed Berkshire Hathaway had purchased 25.92 million Chubb shares valued at over $6.717 billion.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Spire Global, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPIR#NYSE">SPIR</a>) dipped 23.7% to $8.65 after the company reported mixed first-quarter financial results on Wednesday.</li>
<li>a.k.a. Brands Holding Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AKA#NYSE">AKA</a>) shares declined 22.7% to $22.80.</li>
<li>Eyenovia, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EYEN#NASDAQ">EYEN</a>) fell 22% to $0.8291 after the company reported worse-than-expected first-quarter financial results.</li>
<li>Omeros Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OMER#NASDAQ">OMER</a>) fell 21.1% to $3.29 after the company announced a wider-than-expected quarterly loss.</li>
<li>Reliance Global Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RELI#NASDAQ">RELI</a>) declined 19.2% to $0.2994. &#8211; Reliance Global Group is expected to host a conference call Monday, May 20, to discuss financial results for the first quarter.</li>
<li>Tian Ruixiang Holdings Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIRX#NASDAQ">TIRX</a>) dipped 17.8% to $2.81.</li>
<li>Rekor Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REKR#NASDAQ">REKR</a>) declined 16.6% to $1.51 after the company reported worse-than-expected first-quarter financial results.</li>
<li>Sadot Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SDOT#NASDAQ">SDOT</a>) fell 16.6% to $0.2855 following first-quarter financial results.</li>
<li>KULR Technology Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KULR#NYSE">KULR</a>) shares fell 14.8% to $0.3976 after the company announced worse-than-expected first-quarter financial results.</li>
<li>AERWINS Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AWIN#NASDAQ">AWIN</a>) shares fell 14% to $5.40 after jumping 132% on Wednesday.</li>
<li>GameStop Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GME#NYSE">GME</a>) shares fell 13.8% to $34.06 after dipping around 19% on Wednesday.</li>
<li>NICE Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NICE#NASDAQ">NICE</a>) declined 11.8% to $201.01 after the company reported first-quarter financial results. The company issued second-quarter adjusted revenue guidance with its midpoint below estimates.</li>
<li>Gambling.com Group Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GAMB#NASDAQ">GAMB</a>) fell 9.8% to $7.64 after the company issued first-quarter financial results. Also, the company cut its FY24 revenue guidance below estimates.</li>
<li>AMC Entertainment Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMC#NYSE">AMC</a>) shares declined 9% to $4.9904 after tumbling 20% on Wednesday.</li>
<li>Petco Health and Wellness Company, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) dipped 8.4% to $2.39. The company recently appointed Glenn Murphy as Executive Chairman of the Board of Directors, effective immediately.</li>
<li>AdTheorent Holding Company, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADTH#NASDAQ">ADTH</a>) declined 7.4% to $3.1750. AdTheorent reported withdrawal of acquisition proposal from third party.</li>
<li>Dada Nexus Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DADA#NASDAQ">DADA</a>) shares fell 7% to $1.8688 following weak quarterly results.</li>
<li>Coinbase Global, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>) fell 4.3% to $210.53.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/24/05/38872018/top-5-utilities-stocks-you-may-want-to-dump-in-may">Top 5 Utilities Stocks You May Want To Dump In May</a>

Intraday Update

Movers

ADTH

ASTS

AWIN

BMTX

BRSH

BSFC

COIN

CRBG

CRKN

DADA

EXTR

EYEN

FFIE

FLNT

GAMB

GOOS

GWAV

KULR

LSDI

LSPD

MGNI

NICE

OMER

PEGY

REKR

RELI

SBOW

SDOT

SINT

SPIR

TIRX

TRUP

TSRI

WOOF

Why Fluent Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Needham analyst Chris Pierce reiterates ACV Auctions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACVA#NASDAQ">ACVA</a>) with a Buy and maintains $23 price target.

ACVA

Needham Reiterates Buy on ACV Auctions, Maintains $23 Price Target

<a href="https://twitter.com/POTUS/status/1791152464617431389" title="https://twitter.com/POTUS/status/1791152464617431389">https://twitter.com/POTUS/status/1791152464617431389</a>

Macro Economic Events

Politics

Legal

Economics

General

CRON

FLGC

GRWG

MASSIVE INTERACTIVE NV by Massive Interactive, Inc.

HUGE

IMCC

LFLY

MAPS

MSOS

SNDL

TLRY

President Biden Posts On X "Too Many Lives Have Been Upended Because Of Our Failed Approach To Marijuana. So Today, The @TheJusticeDept Is Taking The Next Step To Reclassify Marijuana From A Schedule I To A Schedule Iii Drug Under Federal Law."

Raymond James analyst Stephen Laws maintains Starwood Prop Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STWD#NYSE">STWD</a>) with a Strong Buy and lowers the price target from $23.5 to $23.

STWD

Raymond James Maintains Strong Buy on Starwood Prop Trust, Lowers Price Target to $23

Raymond James analyst John Ransom upgrades GoodRx Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDRX#NASDAQ">GDRX</a>) from Market Perform to Outperform and announces $10 price target.

Upgrades

GDRX

Raymond James Upgrades GoodRx Holdings to Outperform, Announces $10 Price Target

Bitcoin&#8217;s (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) rally to $66,000, marking its best-performing day since March 20, has sparked a range of reactions from <a href="https://www.benzinga.com/markets/cryptocurrency/24/05/38878472/before-you-trust-another-crypto-guru-read-this-studys-results">prominent crypto traders</a>.
What Happened: Trader Kevin <a href="https://twitter.com/Kev_Capital_TA/status/1791054607038255213">suggests</a> that Bitcoin may experience a minor pullback but remains optimistic about its upward trajectory. "BTC looks like it wants to wipe out some late longs which is totally fine. Inevitably, the daily says we're going higher," indicating that short-term corrections are normal and won't deter the long-term bullish trend.
In line with this cautious optimism, Ali Martinez <a href="https://twitter.com/ali_charts/status/1791044603442757897">points</a> to a technical indicator signaling a brief correction. He adds, "The TD Sequential presents a sell signal on the Bitcoin 4-hour chart, anticipating a one to four candlesticks correction for BTC." This implies a short-term dip before potentially resuming its upward path.
On the more bullish end of the spectrum, Jelle <a href="https://twitter.com/CryptoJelleNL/status/1791033350611694028">highlights</a> a significant technical confirmation, noting that &#8220;Yesterday&#8217;s daily close confirmed the Power of Three setups for Bitcoin.&#8221; He targets $82,000. 
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Yesterday&#39;s daily close confirmed the Power of Three setup for <a href="https://twitter.com/hashtag/Bitcoin?src=hash&amp;ref_src=twsrc%5Etfw">#Bitcoin</a>! Target: $82,000. Send it! <a href="https://t.co/Ap6VW6LZFE">https://t.co/Ap6VW6LZFE</a> <a href="https://t.co/9UamATEgyx">pic.twitter.com/9UamATEgyx</a>
&mdash; Jelle (@CryptoJelleNL) <a href="https://twitter.com/CryptoJelleNL/status/1791033350611694028?ref_src=twsrc%5Etfw">May 16, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/05/38870019/spot-bitcoin-etfs-pocket-303m-net-inflows-on-wednesday-stars-seem-to-be-aligning-on-this-b">Spot Bitcoin ETFs Pocket $303M Net Inflows On Wednesday: &#8216;Stars Seem To Be Aligning On This Breakout,&#8217; Analytics Firm Writes</a>
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/events/digital-assets/"><img loading="lazy" decoding="async" width="300" height="250" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/03/29155259/905735A6-57D3-4874-9AA1-75D037842DB3-2.gif" alt="Benzinga Future of Digital Assets conference" class="wp-image-270548" /></a></figure>
Why It Matters: Lookonchain <a href="https://twitter.com/lookonchain/status/1791026638635118756">data</a> shows a whale purchased another 102 BTC, worth $62.7 million. Since March 6 the whale collected 3,385 BTC worth $232.15 million at an average buying cost of $68,579. Based on current prices, the whale is still facing a loss of $8.08 million.
IntoTheBlock <a href="https://app.intotheblock.com/">data</a> notes 95% of Bitcoin holders making a profit at current levels, compared to 91% of holders the prior day. Transactions greater than $100,000 surged to 10,162 transactions as of May 15 from 7,508 transactions as of May 14.
Meanwhile, Bitcoin's daily active addresses rose by 5.6% and large transaction volume increased by 24.3%.
Price Action: In the past 24 hours, Bitcoin&#8217;s price increased 0.6% to trade at $65,203.90 at the time of writing.
What&#8217;s Next: The influence of&nbsp;<a href="https://www.benzinga.com/money/is-bitcoin-a-good-investment" target="_blank" rel="noreferrer noopener">Bitcoin as an institutional asset class</a>&nbsp;is expected to be thoroughly explored at Benzinga&#8217;s upcoming&nbsp;<a href="https://www.benzinga.com/events/digital-assets/agenda/" target="_blank" rel="noreferrer noopener">Future of Digital Assets</a>&nbsp;event on Nov. 19.
Read Next: <a href="https://www.benzinga.com/markets/cryptocurrency/24/05/38857448/bitcoin-ethereum-dogecoin-spike-on-good-macro-news-so-far-so-good-says-bullish-trader">Bitcoin, Ethereum, Dogecoin Spike On Good Macro News: &#8216;So Far, So Good,&#8217; Says Bullish Trader</a>
This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Image created using artificial intelligence with Midjourney.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

Bitcoin's Rally Splits Trader Opinions: 'Daily Says We're Going Higher' But One Indicator Presents A 'Sell Signal On The 4H Chart'

Canaccord Genuity analyst Joseph Vafi reiterates Hut 8 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HUT#NASDAQ">HUT</a>) with a Buy and maintains $14 price target.

Canaccord Genuity Reiterates Buy on Hut 8, Maintains $14 Price Target

ChargePoint Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHPT#NYSE">CHPT</a>) shares are trading down Thursday. The company announced new technology to better support the future of <a href="https://www.benzinga.com/news/24/05/38762667/tesla-charging-shakeup-may-disrupt-biden-ev-plans">the trucking industry</a>.
What Happened: ChargePoint announced its support for the Megawatt Charging System (MCS), the latest addition to ChargePoint&#8217;s leading DC fast charging lineup. The company said the system is expected to be capable of providing enough energy to power approximately 1,000 homes.
The MCS cable and connector will be available on ChargePoint&#8217;s PowerLink 2000 stations,&nbsp;part of the modular Express Plus DC fast charging platform.
The new system currently offers up to 1.2 megawatts of power. The charging system is expected to enable output of up to 3 megawatts in the future. The ChargePoint system is also designed for charging in marine and aviation applications. The immense rate of charge is expected to help enable the electrification of commercial trucking, the company said.
&#8220;Megawatt technology is the first step toward electrifying the commercial trucking industry,&#8221; said Hossein Kazemi, CTO for Hardware at ChargePoint. 
&#8220;Megawatt charging solves one half of the electrification equation for trucking. The companies developing electric trucks can now leverage this infrastructure to test and enable their vehicles until they meet – or even exceed – the distances covered by internal combustion trucks.&#8221;
Separately, ChargePoint on Wednesday announced that it will report <a href="https://www.benzinga.com/calendars/earnings">financial results for the first quarter</a> after the market close on June 5. Analyst estimates are calling for a loss of 13 cents per share and revenue of $105.791 million, according to data from <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Related Link:<a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/05/38798876/3-clean-tech-stocks-with-over-40-upside-per-jpmorgan-analysts"> 3 Clean Tech Stocks With Over 40% Upside Per JPMorgan Analysts</a>
CHPT Price Action: At the time of writing, ChargePoint shares were down 1.99% at $1.85, per <a href="https://pro.benzinga.com/dashboard">Benzinga Pro.</a>
Image: <a href="https://commons.wikimedia.org/wiki/File:Ct4k_public_domain_image.JPG">Wikimedia </a><a href="https://commons.wikimedia.org/wiki/Category:ChargePoint">Commons</a>.

CHPT

What's Going On With ChargePoint Holdings Stock Today?

WIIM

MUFG

Shares of Japanese bank stocks are trading lower after GDP data came in worse-than-expected.

Director Francis Ford Coppola shot to international stardom in the 1970s following his critically <a href="https://www.rottentomatoes.com/celebrity/francis_ford_coppola">acclaimed</a> films &#8220;The Godfather,&#8221; &#8220;The Godfather Part II&#8221; and &#8220;Apocalypse Now.&#8221; His latest, the self-financed film &#8220;Megalopolis,&#8221; is set to premiere on Thursday and has the potential to <a href="https://www.benzinga.com/topic/movies">shake-up the film industry</a>.
Production Challenges: Coppola has tried to make the film for more than 40 years but could not acquire financing. The director previously worked with Paramount Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PARA#NASDAQ">PARA</a>)(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PARAA#NASDAQ">PARAA</a>) to finance &#8220;The Godfather.&#8221;
In what could be his final film, Coppola sold a portion of his wine empire to self-finance the film&#8217;s reported $120 million budget, according to <a href="https://www.hollywoodreporter.com/movies/movie-news/megalopolis-francis-ford-coppola-challenges-distribution-1235867556/">The Hollywood Reporter</a>. 
The Premiere: The film will <a href="https://www.festival-cannes.com/en/f/megalopolis/">premiere</a> on Thursday at Cannes Film Festival, considered one of the world&#8217;s most prestigious film festivals, in a litmus test of its future commercial potential.
Coppola has <a href="https://www.festival-cannes.com/en/p/francis-coppola/">won</a> the festival&#8217;s top award, the Palme D&#8217;Or, twice; for &#8220;The Conversation&#8221; in 1974 and &#8220;Apocalypse Now&#8221; in 1979. The latter had innumerable production challenges, eerily similar to &#8220;Megalopolis.&#8221;
The film ensemble features Adam Driver, Shia LaBeouf, Nathalie Emmanuel, Giancarlo Esposito, Aubrey Plaza, Jon Voight, Talia Shire, Laurence Fishburne and Dustin Hoffman, among others.
Now Read:<a href="https://www.benzinga.com/markets/equities/24/05/38876672/amc-entertainment-a-dead-company-walking-says-bear-cave-report"> AMC Entertainment: A &#8216;Dead Company Walking,&#8217; Says Bear Cave Report</a>
Distribution Challenges: The film has thus far been unable to find a domestic distributor, according to The Hollywood Reporter. A pre-screening for executives from Sony Group Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SONY#NYSE">SONY</a>), Comcast Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMCSA#NASDAQ">CMCSA</a>) subsidiary NBCUniversal and others did not result in the film gaining a distribution partner.
Executives were reportedly concerned the film was too &#8220;experimental&#8221; for Coppola&#8217;s envisioned $80 million to $100 million marketing spend. "There is just no way to position this movie,&#8221; said one reporter.
Despite concerns, IMAX Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IMAX#NYSE">IMAX</a>) CEO Richard Gelfond confirmed at a Cannes event on Thursday that the film would get a release in IMAX. Variety <a href="https://variety.com/2024/film/news/francis-ford-coppola-megalopolis-in-talks-french-distribution-deal-le-pacte-1235979859/">reported</a> that Amazon.com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) and Apple Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) could be still in the running for acquiring distribution rights.
Industry Outlook: In recent years, film distributors have increasingly <a href="https://www.benzinga.com/general/entertainment/24/01/36522359/whats-next-after-mario-movie-success-zelda-movie-coming-mario-creator-hints-at-more-films">preferred</a> movie franchises rather than experimental films for theater releases.
Although artistic efforts have struggled in theaters, they have found a home on streaming platforms. Apple spent over $300 in <a href="https://www.benzinga.com/24/03/37558754/apples-1b-gamble-on-3-blockbusters-analyzing-box-office-results-streaming-impact-and-oscar-nominatio">financing</a> the Martin Scorsese production &#8220;Killers of the Flower Moon.&#8221;
If &#8220;Megalopolis&#8221; succeeds, it could spell a surprising shift in industry strategy.
Also Read: <a href="https://www.benzinga.com/general/entertainment/24/05/38804938/if-you-invested-1-000-in-gamestop-stock-when-dumb-money-was-released-in-movie-theaters-here">If You Invested $1,000 In GameStop Stock When &#8216;Dumb Money&#8217; Was Released In Movie Theaters, Here&#8217;s How Much You&#8217;d Have Today</a>
Photo: Via IMDb

Entertainment

Global

AAPL

AMZN

CMCSA

IMAX

PARA

PARAA

Sony Group Corporation American Depositary Shares

SONY

Francis Ford Coppola Spent $120M Self-Financing Passion Project: What The Gambit Could Mean For The Film Industry

Providing a diverse range of perspectives from bullish to bearish, 4 analysts have published ratings on Ralph Lauren (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RL#NYSE">RL</a>) in the last three months.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for Ralph Lauren, revealing an average target of $206.75, a high estimate of $250.00, and a low estimate of $185.00. This upward trend is evident, with the current average reflecting a 4.07% increase from the previous average price target of $198.67.
<img src="https://www.benzinga.com/files/images/story/2024/1715878904_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
The perception of Ralph Lauren by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Jay Sole</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$250.00</td>
<td>$244.00</td>
</tr>
<tr>
<td>John Kernan</td>
<td>TD Cowen</td>
<td>Raises</td>
<td>Buy</td>
<td>$197.00</td>
<td>$192.00</td>
</tr>
<tr>
<td>Ashley Helgans</td>
<td>Jefferies</td>
<td>Announces</td>
<td>Buy</td>
<td>$195.00</td>
<td>-</td>
</tr>
<tr>
<td>Ike Boruchow</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$185.00</td>
<td>$160.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Ralph Lauren. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Ralph Lauren compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Ralph Lauren's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Ralph Lauren's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/RL/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Ralph Lauren analyst ratings.</a>
<h2>Discovering Ralph Lauren: A Closer Look</h2>
Founded by designer Ralph Lauren in 1967 in New York City, Ralph Lauren Corp. designs, markets, and distributes lifestyle products in North America, Europe, and Asia. Its products include apparel, footwear, eyewear, jewelry, handbags, home goods, and fragrances. The company's brands include Ralph Lauren Collection, Polo Ralph Lauren, and Lauren Ralph Lauren. Distribution channels for Ralph Lauren include wholesale (department stores and specialty stores), retail (company-owned retail stores and e-commerce), and licensing.
<h3>Financial Insights: Ralph Lauren</h3>
Market Capitalization Analysis: Above industry benchmarks, the company's market capitalization emphasizes a noteworthy size, indicative of a strong market presence.
Revenue Growth: Ralph Lauren's remarkable performance in 3 months is evident. As of 31 December, 2023, the company achieved an impressive revenue growth rate of 5.55%. This signifies a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Consumer Discretionary sector.
Net Margin: Ralph Lauren's net margin is impressive, surpassing industry averages. With a net margin of 14.3%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Ralph Lauren's ROE stands out, surpassing industry averages. With an impressive ROE of 11.2%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Ralph Lauren's ROA stands out, surpassing industry averages. With an impressive ROA of 4.03%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: With a below-average debt-to-equity ratio of 1.07, Ralph Lauren adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>How Are Analyst Ratings Determined?</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Deep Dive Into Ralph Lauren Stock: Analyst Perspectives (4 Ratings)

American Healthcares (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AHR#NYSE">AHR</a>) underwent analysis by 11 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">7</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $16.18, along with a high estimate of $18.00 and a low estimate of $14.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 4.82%. 
<img src="https://www.benzinga.com/files/images/story/2024/1715878895_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
A comprehensive examination of how financial experts perceive American Healthcares is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Aaron Hecht</td>
<td>JMP Securities</td>
<td>Maintains</td>
<td>Market Outperform</td>
<td>$16.00</td>
<td>-</td>
</tr>
<tr>
<td>Michael Lewis</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$16.00</td>
<td>$17.00</td>
</tr>
<tr>
<td>Michael Lewis</td>
<td>Truist Securities</td>
<td>Maintains</td>
<td>Buy</td>
<td>$17.00</td>
<td>-</td>
</tr>
<tr>
<td>Aaron Hecht</td>
<td>JMP Securities</td>
<td>Maintains</td>
<td>Market Outperform</td>
<td>$16.00</td>
<td>-</td>
</tr>
<tr>
<td>Anthony Powell</td>
<td>Barclays</td>
<td>Announces</td>
<td>Overweight</td>
<td>$18.00</td>
<td>-</td>
</tr>
<tr>
<td>Brian Cheng</td>
<td>RBC Capital</td>
<td>Announces</td>
<td>Outperform</td>
<td>$15.00</td>
<td>-</td>
</tr>
<tr>
<td>Aaron Hecht</td>
<td>JMP Securities</td>
<td>Announces</td>
<td>Market Outperform</td>
<td>$16.00</td>
<td>-</td>
</tr>
<tr>
<td>Michael Lewis</td>
<td>Truist Securities</td>
<td>Announces</td>
<td>Buy</td>
<td>$17.00</td>
<td>-</td>
</tr>
<tr>
<td>Ronald Kamdem</td>
<td>Morgan Stanley</td>
<td>Announces</td>
<td>Overweight</td>
<td>$17.00</td>
<td>-</td>
</tr>
<tr>
<td>Michael Griffin</td>
<td>Citigroup</td>
<td>Announces</td>
<td>Neutral</td>
<td>$14.00</td>
<td>-</td>
</tr>
<tr>
<td>Austin Wurschmidt</td>
<td>Keybanc</td>
<td>Announces</td>
<td>Overweight</td>
<td>$16.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to American Healthcares. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of American Healthcares compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of American Healthcares's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of American Healthcares's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/AHR/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on American Healthcares analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>Delving into American Healthcares's Background</h2>
American Healthcare REIT Inc is a healthcare-focused real estate investment trust. It owns a diversified portfolio of clinical healthcare real estate properties, focusing primarily on medical office buildings, skilled nursing facilities, senior housing, hospitals, and other healthcare-related facilities. They have four reportable business segments: integrated senior health campuses, outpatient medical, triple-net leased properties and SHOP. It generates majority of revenue through Integrated Senior Health Campuses segment.
<h3>Breaking Down American Healthcares's Financial Performance</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Over the 3 months period, American Healthcares showcased positive performance, achieving a revenue growth rate of 3.52% as of 31 March, 2024. This reflects a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Real Estate sector.
Net Margin: American Healthcares's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of -0.78%, the company may face hurdles in effective cost management.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of -0.24%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): American Healthcares's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of -0.08%, the company may face hurdles in achieving optimal financial returns.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 1.15.
<h2>The Basics of Analyst Ratings</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Unveiling 11 Analyst Insights On American Healthcares

7 analysts have shared their evaluations of Urban Outfitters (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/URBN#NASDAQ">URBN</a>) during the recent three months, expressing a mix of bullish and bearish perspectives.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated Urban Outfitters and provided 12-month price targets. The average target is $41.29, accompanied by a high estimate of $44.00 and a low estimate of $32.00. This current average represents a 0.91% decrease from the previous average price target of $41.67. 
<img src="https://www.benzinga.com/files/images/story/2024/1715878887_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
The perception of Urban Outfitters by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Jay Sole</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$43.00</td>
<td>$42.00</td>
</tr>
<tr>
<td>Corey Tarlowe</td>
<td>Jefferies</td>
<td>Lowers</td>
<td>Underperform</td>
<td>$32.00</td>
<td>$42.00</td>
</tr>
<tr>
<td>Jay Sole</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$42.00</td>
<td>$41.00</td>
</tr>
<tr>
<td>Jay Sole</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$42.00</td>
<td>$41.00</td>
</tr>
<tr>
<td>Simeon Siegel</td>
<td>BMO Capital</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$42.00</td>
<td>$38.00</td>
</tr>
<tr>
<td>Matthew Boss</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$44.00</td>
<td>$46.00</td>
</tr>
<tr>
<td>Dana Telsey</td>
<td>Telsey Advisory Group</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$44.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Urban Outfitters. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Urban Outfitters compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Urban Outfitters's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Capture valuable insights into Urban Outfitters's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/URBN/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Urban Outfitters analyst ratings.</a>
<h2>Unveiling the Story Behind Urban Outfitters</h2>
Founded in 1970, Philadelphia-based Urban Outfitters is an apparel and home goods retailer that operates more than 700 stores and e-commerce in the United States (87% of fiscal 2024 sales) and other regions. Its retail nameplates are Urban Outfitters, Free People, FP Movement, and Anthropologie. Retail accounted for 91% of fiscal 2024 revenue, but the firm also sells products through a wholesale operation, owns some restaurants, and operates a clothing rental and resale business called Nuuly (5% of sales). Urban Outfitters primarily markets to young adults and offers products in categories such as apparel (66% of sales), home goods (16% of sales), accessories (13% of sales), and more.
<h3>Urban Outfitters's Financial Performance</h3>
Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.
Revenue Growth: Urban Outfitters's revenue growth over a period of 3 months has been noteworthy. As of 31 January, 2024, the company achieved a revenue growth rate of approximately 7.34%. This indicates a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Consumer Discretionary sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 3.21%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Urban Outfitters's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of 2.3%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): Urban Outfitters's ROA excels beyond industry benchmarks, reaching 1.16%. This signifies efficient management of assets and strong financial health.
Debt Management: Urban Outfitters's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.51.
<h2>How Are Analyst Ratings Determined?</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

URBN

Where Urban Outfitters Stands With Analysts

Analysts' ratings for Progressive (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PGR#NYSE">PGR</a>) over the last quarter vary from bullish to bearish, as provided by 20 analysts.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">6</td>
<td style="text-align: right;">7</td>
<td style="text-align: right;">7</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">6</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $233.0, a high estimate of $286.00, and a low estimate of $190.00. This upward trend is apparent, with the current average reflecting a 6.62% increase from the previous average price target of $218.53.
<img src="https://www.benzinga.com/files/images/story/2024/1715878875_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
The analysis of recent analyst actions sheds light on the perception of Progressive by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Joshua Shanker</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$286.00</td>
<td>$279.00</td>
</tr>
<tr>
<td>Michael Zaremski</td>
<td>BMO Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$235.00</td>
<td>$234.00</td>
</tr>
<tr>
<td>Brian Meredith</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$218.00</td>
<td>$216.00</td>
</tr>
<tr>
<td>Joshua Shanker</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$273.00</td>
<td>$279.00</td>
</tr>
<tr>
<td>Michael Ward</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Neutral</td>
<td>$225.00</td>
<td>$202.00</td>
</tr>
<tr>
<td>Bob Huang</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$256.00</td>
<td>$247.00</td>
</tr>
<tr>
<td>Yaron Kinar</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Buy</td>
<td>$245.00</td>
<td>$241.00</td>
</tr>
<tr>
<td>Elyse Greenspan</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$238.00</td>
<td>$232.00</td>
</tr>
<tr>
<td>Bob Huang</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$247.00</td>
<td>$228.00</td>
</tr>
<tr>
<td>Meyer Shields</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$200.00</td>
<td>$190.00</td>
</tr>
<tr>
<td>Jimmy Bhullar</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$202.00</td>
<td>$171.00</td>
</tr>
<tr>
<td>Joshua Shanker</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$264.00</td>
<td>$265.00</td>
</tr>
<tr>
<td>Paul Newsome</td>
<td>Piper Sandler</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$240.00</td>
<td>-</td>
</tr>
<tr>
<td>Vikram Gandhi</td>
<td>HSBC</td>
<td>Raises</td>
<td>Hold</td>
<td>$200.00</td>
<td>$174.00</td>
</tr>
<tr>
<td>Alex Scott</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Neutral</td>
<td>$216.00</td>
<td>$161.00</td>
</tr>
<tr>
<td>Meyer Shields</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$190.00</td>
<td>$185.00</td>
</tr>
<tr>
<td>Harry Fong</td>
<td>Roth MKM</td>
<td>Raises</td>
<td>Buy</td>
<td>$235.00</td>
<td>$215.00</td>
</tr>
<tr>
<td>Michael Ward</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Neutral</td>
<td>$202.00</td>
<td>$192.00</td>
</tr>
<tr>
<td>Bob Huang</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$227.00</td>
<td>$185.00</td>
</tr>
<tr>
<td>Joshua Shanker</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$261.00</td>
<td>$256.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Progressive. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Progressive compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Progressive's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Progressive's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/PGR/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Progressive analyst ratings.</a>
<h2>Get to Know Progressive Better</h2>
Progressive underwrites private and commercial auto insurance and specialty lines; it has almost 20 million personal auto policies in force and is one of the largest auto insurers in the United States. Progressive markets its policies through independent insurance agencies in the US and Canada and directly via the internet and telephone. Its premiums are split roughly equally between the agent and the direct channel. The company also offers commercial auto policies and entered homeowners insurance through an acquisition in 2015.
<h3>Breaking Down Progressive's Financial Performance</h3>
Market Capitalization: Positioned above industry average, the company's market capitalization underscores its superiority in size, indicative of a strong market presence.
Revenue Growth: Progressive displayed positive results in 3 months. As of 31 March, 2024, the company achieved a solid revenue growth rate of approximately 20.56%. This indicates a notable increase in the company's top-line earnings. When compared to others in the Financials sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: Progressive's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of 13.43%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Progressive's ROE excels beyond industry benchmarks, reaching 11.13%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Progressive's ROA excels beyond industry benchmarks, reaching 2.53%. This signifies efficient management of assets and strong financial health.
Debt Management: Progressive's debt-to-equity ratio stands notably higher than the industry average, reaching 0.32. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
<h2>How Are Analyst Ratings Determined?</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Beyond The Numbers: 20 Analysts Discuss Progressive Stock

Evercore ISI Group maintains Savara (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SVRA#NASDAQ">SVRA</a>) with a Outperform and lowers the price target from $10 to $7.

SVRA

Evercore ISI Group Maintains Outperform on Savara, Lowers Price Target to $7

Trading Ideas

BRK/B

CRWD

CNBC Halftime Report Final Trades: Bank Of America, CrowdStrike, Citigroup, Berkshire Hathaway - B Shares

Precious Metals Royalty And Streaming Companies: The September Report

Strong Earnings, Weak Stock: Unpacking EMX Royalty's Q3

These Basic Materials stocks are trading higher:-WD-40 Company (WDFC) stock is trading at $270.70, an increase of $34.09, or 14.1%, on high volume.  W D 40 Company gets a Sentiment Score of Bullish from InvestorsObserver and receives an average analyst recommendation of Buy with a price target of $198.00.  WDFC's next ex-d

Basic Materials Stocks Moving Up and Down Wednesday: WDFC, ASPI, TGB, GATO, HYMC, SSL, ASCUF, ATLX

Catalyst Watch: Tesla, Netflix and Procter & Gamble head into the earnings confessional

Stocks To Watch: Eyes On Chipmakers, Tesla, Netflix And BrightSpring IPO

Catalyst Watch: Disney earnings, Apple iPad event and Fed speakers back on the circuit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Latest News for Arizona Sonoran Copper Stock (OTC:ASCUF)

Thursday, April 28, 2022